Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study Evaluating Ivonescimab in Combination With Chemotherapy for First- and Second-line Treatment of Advanced or Metastatic Gastric and Gastroesophageal Adenocarcinoma Patients

NCT06846346 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT06846346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06846346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study Evaluating Ivonescimab in Combination With Chemotherapy for First- and Second-line Treatment of Advanced or Metastatic Gastric and Gastroesophageal Adenocarcinoma Patients
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Recruiting
Start date
November 20, 2025
Completion date
September 30, 2028
Enrollment
88 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

advanced esophageal adenocarcinoma, advanced gastric adenocarcinoma, metastatic esophageal adenocarcinoma, metastatic gastric adenocarcinoma